All News #Library
Biotech
Curateq Biologics Reports Phase 3 Results for BP11
07 Apr 2026 //
EXPRESSPHARMA
Aurobindo`s Unit Receive UK Approval for Biosimilar Breast Cancer
27 Aug 2025 //
BUSINESS STD
Aurobindo arm’s Biosimilar Gets Marketing Nod From U.K.’s MHRA
14 May 2025 //
THEHINDU
Aurobindo Pharma acquires 80% stake in Tergene Biotech
01 Mar 2025 //
BUSINESS STD
Aurobindo approves acquisition of 80% stake in Tergene Biotech
08 Feb 2025 //
BUSINESS STD
CuraTeQ Biologics receives positive opinion for biosimilar Dyrupeg from EMA
03 Feb 2025 //
INDPHARMAPOST
EMA Grants GMP Certificate to CuraTeQ Biosimilars Facility
12 Nov 2024 //
FINANCIALXPRESS
Aurobindo arm extends negotiations deadline with MSD for CMO operations
28 Mar 2024 //
ECONOMIC TIMES
Aurobindo Pharma gets USFDA nod for HIV drug
29 Nov 2023 //
ECONOMIC TIMES
Aurobindo`s subsidiary to withdraw mkt authorization for EU 2 biosimilar
25 Jun 2023 //
INDIANPHARMAPOST

Market Place
Sourcing Support